Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
New drugs in clinical trials for muscle-wasting diseases could become the next big thing for athletes.
Reading the DNA of fetuses is the next frontier of the genome revolution. Do you really want to know the genetic destiny of your unborn child?
Obama calls for $100 million to develop new technologies to understand the brain.
Devices from two startups could be used to treat people with anxiety disorders—and one of the devices may eventually diagnose pain.
The Harvard chemist talks about the problem of solving problems.
A twins study sparks debate over the usefulness of medical genome sequencing.
Google would have had to fix a balkanized U.S. health-care system to make the service catch on.
After years of controversy, a therapy based on human embryonic stem cells is finally being tested in humans. The treatment holds out hope to paralyzed people, but at how great a risk?
The device could help caregivers anticipate meltdowns in autistic children.